Dr. Killian Hurley:

It is a rare event. Approximately between 20 and 30 take place per year. At most, they managed to do approximately 40 patients in a year in the Mater. Transplants are for a select group of patients that meet those certain really strict criteria. While it is really important for those patients, it is not for everybody. Yet, anti-fibrotic therapy is something that could be rolled out to all patients if they had the right care and the right kind of team taking care of them.